Diagnostic value of FDG‐PET for lymph node metastasis and outcome of surgery for biliary cancer

Histopathologically confirmed lymph node metastasis is a prognostic factor in the surgical treatment of biliary tract cancer, however, preoperative diagnosis is still difficult even with computed tomography. FDG‐PET has been used for the diagnosis of cancer and metastatic lesions. Herein, we retrospectively evaluated the utility of FDG‐PET for detection of lymph node metastasis in biliary tract cancer.

[1]  Y. Suga,et al.  Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size. , 2010, European journal of radiology.

[2]  Y. Takeda,et al.  Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer , 2010, Journal of surgical oncology.

[3]  Y. Takeda,et al.  Impact of postoperative irradiation after non‐curative resection of hilar biliary cancer , 2009, Journal of surgical oncology.

[4]  H. Furukawa,et al.  Prognostic importance of standardized uptake value on F‐18 fluorodeoxyglucose‐positron emission tomography in biliary tract carcinoma , 2009, Journal of surgical oncology.

[5]  S. Kanazawa,et al.  The SUVmax of 18F-FDG PET Correlates With Histological Grade in Endometrial Cancer , 2009, International Journal of Gynecologic Cancer.

[6]  M. Highley,et al.  Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study , 2009, British Journal of Cancer.

[7]  P. Grigsby,et al.  18F-Fluorodeoxyglucose-Positron Emission Tomography and Pathologic Tumor Size in Early-Stage Invasive Cervical Cancer , 2009, International Journal of Gynecologic Cancer.

[8]  Seung Woo Park,et al.  The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection , 2009, Journal of surgical oncology.

[9]  G. Gerken,et al.  Preoperative assessment of hilar cholangiocarcinoma by dual‐modality PET/CT , 2008, Journal of surgical oncology.

[10]  S. Beghelli,et al.  Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes after Curative Resection of Ampulla of Vater Carcinoma , 2008, Annals of Surgical Oncology.

[11]  D. Gouma,et al.  Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater , 2008, The British journal of surgery.

[12]  K. Tsuchiya,et al.  Outcome of Surgical Treatment of Hilar Cholangiocarcinoma , 2008, Journal of Gastrointestinal Surgery.

[13]  H. Furukawa,et al.  Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology , 2008, European Radiology.

[14]  J. Lee,et al.  Usefulness of 18F‐fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas , 2008, Journal of gastroenterology and hepatology.

[15]  Jae Seung Kim,et al.  Clinical Role of 18F-FDG PET-CT in Suspected and Potentially Operable Cholangiocarcinoma: A Prospective Study Compared With Conventional Imaging , 2008, The American Journal of Gastroenterology.

[16]  Myeong-Jin Kim,et al.  Comparison of CT and MRI for presurgical characterization of paraaortic lymph nodes in patients with pancreatico-biliary carcinoma. , 2008, World journal of gastroenterology.

[17]  Y. Nishiyama,et al.  Comparison of early and delayed FDG PET for evaluation of biliary stricture , 2007, Nuclear medicine communications.

[18]  S. Kondo,et al.  Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer , 2007, The British journal of surgery.

[19]  Jin‐Young Jang,et al.  Recurrence and Prognostic Factors of Ampullary Carcinoma after Radical Resection: Comparison with Distal Extrahepatic Cholangiocarcinoma , 2007, Annals of Surgical Oncology.

[20]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[21]  W. Jochum,et al.  Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. , 2006, Journal of hepatology.

[22]  K. Hatakeyama,et al.  Clinical Significance of Lymph Node Micrometastasis in Ampullary Carcinoma , 2006, World Journal of Surgery.

[23]  Seung‐Mo Hong,et al.  The Number of Metastatic Lymph Nodes in Extrahepatic Bile Duct Carcinoma as a Prognostic Factor , 2005, The American journal of surgical pathology.

[24]  S. Kondo,et al.  CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer , 2005, Journal of Gastroenterology.

[25]  T. Takada,et al.  Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. , 2009, Journal of hepato-biliary-pancreatic surgery.

[26]  최진섭,et al.  The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection , 2009 .

[27]  W. Chapman,et al.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.

[28]  S. Maithel,et al.  Impact of Regional Lymph Node Evaluation in Staging Patients With Periampullary Tumors , 2006, Annals of Surgical Oncology.